Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies
نویسندگان
چکیده
منابع مشابه
Pharmacotherapy for borderline personality disorder: NICE guideline.
In their review of drug treatments for borderline personality disorder, Lieb et al, 1 despite considering similar evidence, draw largely different conclusions from those we drew when developing the National Institute for Health and Clinical Excellence (NICE) guideline. 2 Lieb et al recommend a range of drugs. These include anticonvulsants for affective dysregulation symptoms (topiramate, valpro...
متن کاملPersonality Dimensions of Temperament and Character in Patients with Borderline Personality Disorder and Bipolar Disorder II
Introduction: The purpose of this study was to investigate and compare personality dimensions of temperament and character in patients with borderline personality and bipolar II disorders in order to evaluate the hypothesis of “belonging of borderline personality disorder in moods disturbance spectrum.” Materials and Methods: 43 patients with borderline personality disorder, 47 patients with bi...
متن کاملBorderline Personality Disorder: An Overview
Although the term borderline has been in clinical use since the late 1930s, it only became an official Axis II diagnosis in 1980 with the publication of DSM-III. Currently, DSM-IV-TR emphasizes that patients with borderline personality disorder (BPD) show a "instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a ...
متن کاملBorderline Personality Disorder: An Overview
July 2004, Vol. XXI, Issue 8 Although the term borderline has been in clinical use since the late 1930s, it only became an official Axis II diagnosis in 1980 with the publication of DSM-III. Currently, DSM-IV-TR emphasizes that patients with borderline personality disorder (BPD) show a "instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by earl...
متن کاملBiosimilars: An Update on Clinical Trials (Review of Published and Ongoing Studies).
Biosimilars represent a new trend in the treatment of many immune-mediated inflammatory diseases. Regulatory requirements for approval of biosimilars are different from those of originators and rely mostly on the evidence generated from bioequivalence studies and in particular from RCTs. Our goal in this review was to search for relevant studies from randomized controlled trials on the biosimil...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Psychiatry Reports
سال: 2020
ISSN: 1523-3812,1535-1645
DOI: 10.1007/s11920-020-01164-1